A new trading day began on Friday, with Intensity Therapeutics Inc (NASDAQ: INTS) stock price up 7.10% from the previous day of trading, before settling in for the closing price of $0.25. INTS’s price has ranged from $0.19 to $4.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -23.29% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 46.58%. With a float of $14.05 million, this company’s outstanding shares have now reached $26.17 million.
In an organization with 16 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Intensity Therapeutics Inc (INTS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Intensity Therapeutics Inc is 46.12%, while institutional ownership is 10.32%.
Intensity Therapeutics Inc (INTS) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.25 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.46% during the next five years compared to -23.29% drop over the previous five years of trading.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Here are Intensity Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Intensity Therapeutics Inc (INTS)
Let’s dig in a bit further. During the last 5-days, its volume was 5.22 million. That was better than the volume of 1.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 45.54%.
During the past 100 days, Intensity Therapeutics Inc’s (INTS) raw stochastic average was set at 3.66%, which indicates a significant decrease from 48.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0354 in the past 14 days, which was lower than the 0.0940 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3416, while its 200-day Moving Average is $1.6467.
